MX2020004110A - Factor estimulante de colonias de granulocito-macrofago (gm-csf) para tratar infecciones refractarias por micobacterias no tuberculosas. - Google Patents
Factor estimulante de colonias de granulocito-macrofago (gm-csf) para tratar infecciones refractarias por micobacterias no tuberculosas.Info
- Publication number
- MX2020004110A MX2020004110A MX2020004110A MX2020004110A MX2020004110A MX 2020004110 A MX2020004110 A MX 2020004110A MX 2020004110 A MX2020004110 A MX 2020004110A MX 2020004110 A MX2020004110 A MX 2020004110A MX 2020004110 A MX2020004110 A MX 2020004110A
- Authority
- MX
- Mexico
- Prior art keywords
- csf
- refractory non
- treating refractory
- tuberculous mycobacteria
- mycobacteria infections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se refiere a métodos para tratar individuos que padecen de una infección pulmonar por NTM refractaria a tratamiento, por ejemplo, a tratamiento con antibióticos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762572711P | 2017-10-16 | 2017-10-16 | |
EP17198938 | 2017-10-27 | ||
PCT/EP2018/078214 WO2019076883A1 (en) | 2017-10-16 | 2018-10-16 | GM-CSF FOR THE TREATMENT OF NON-TUBERCULAR REFRACTORY MYCOBACTERIAL INFECTIONS |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020004110A true MX2020004110A (es) | 2020-11-06 |
Family
ID=63840864
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020004110A MX2020004110A (es) | 2017-10-16 | 2018-10-16 | Factor estimulante de colonias de granulocito-macrofago (gm-csf) para tratar infecciones refractarias por micobacterias no tuberculosas. |
Country Status (8)
Country | Link |
---|---|
US (1) | US11938169B2 (es) |
EP (1) | EP3697432A1 (es) |
JP (2) | JP2020536973A (es) |
KR (1) | KR20200100603A (es) |
BR (1) | BR112020007395A2 (es) |
CA (1) | CA3079117A1 (es) |
MX (1) | MX2020004110A (es) |
WO (1) | WO2019076883A1 (es) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
US5391485A (en) | 1985-08-06 | 1995-02-21 | Immunex Corporation | DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues |
US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
EP2094290B1 (en) | 2006-11-03 | 2017-07-19 | Drugrecure ApS | Enhancing pulmonary host defense via administration of granulocyte-macrophage colony stimulating factor |
US20170035850A1 (en) | 2014-03-07 | 2017-02-09 | Reponex Pharmaceuticals Aps | Compositions for treating lung infections by airway administration |
CA2949078C (en) | 2014-05-15 | 2022-09-20 | Insmed Incorporated | Methods for treating pulmonary non-tuberculous mycobacterial infections |
US20170165374A1 (en) * | 2015-11-18 | 2017-06-15 | Insmed, Inc. | Compositions and methods for treating bacterial infections |
-
2018
- 2018-10-16 WO PCT/EP2018/078214 patent/WO2019076883A1/en unknown
- 2018-10-16 MX MX2020004110A patent/MX2020004110A/es unknown
- 2018-10-16 KR KR1020207010908A patent/KR20200100603A/ko unknown
- 2018-10-16 JP JP2020542195A patent/JP2020536973A/ja active Pending
- 2018-10-16 EP EP18785968.1A patent/EP3697432A1/en active Pending
- 2018-10-16 US US16/755,178 patent/US11938169B2/en active Active
- 2018-10-16 BR BR112020007395-4A patent/BR112020007395A2/pt unknown
- 2018-10-16 CA CA3079117A patent/CA3079117A1/en active Pending
-
2024
- 2024-02-21 JP JP2024024646A patent/JP2024059779A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2020536973A (ja) | 2020-12-17 |
BR112020007395A2 (pt) | 2020-09-29 |
WO2019076883A1 (en) | 2019-04-25 |
JP2024059779A (ja) | 2024-05-01 |
US11938169B2 (en) | 2024-03-26 |
CA3079117A1 (en) | 2019-04-25 |
US20200237869A1 (en) | 2020-07-30 |
KR20200100603A (ko) | 2020-08-26 |
EP3697432A1 (en) | 2020-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4282489A3 (en) | Treatment of clostridium difficile infection | |
EA201891200A1 (ru) | Композиции, содержащие бактериальные штаммы | |
CL2017000285A1 (es) | Terapia combinada para el tratamiento de un paramixovirus | |
EA201891202A1 (ru) | Композиции, содержащие бактериальные штаммы | |
EA201891201A1 (ru) | Композиции, содержащие бактериальные штаммы | |
EA201890050A1 (ru) | Композиции, содержащие бактериальные штаммы | |
EA201890049A1 (ru) | Композиции, содержащие бактериальные штаммы | |
BR112017001162A2 (pt) | métodos para tratar paramixovírus | |
CY1122805T1 (el) | Ενωσεις και μεθοδοι για την αγωγη βακτηριακων λοιμωξεων | |
GEP20227406B (en) | Chromane monobactam compounds for the treatment of bacterial infections | |
WO2018136617A3 (en) | Bacteria for treating cancer | |
EP3442502A4 (en) | COMPOSITIONS, SYSTEMS, KITS AND METHODS FOR TREATING INFECTION | |
MX2023004969A (es) | Metodos para tratar y prevenir infeccion por c. difficile. | |
EA201791530A1 (ru) | НОВЫЕ N-АЦИЛАРИЛСУЛЬФОНАМИДНЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ АМИНОАЦИЛ-тРНК СИНТЕТАЗЫ | |
MX2017013360A (es) | Métodos para tratar el cáncer. | |
WO2019139176A8 (ja) | ニコチアナ属f1ハイブリットおよびその利用 | |
WO2017161344A8 (en) | Compositions and methods for treating parasitic diseases | |
EP3856213A4 (en) | METHOD OF TREATMENT OF INFECTIONS USING BACTERIA | |
MX2020012990A (es) | Formulaciones de tegavivint y compuestos relacionados. | |
MX2020004110A (es) | Factor estimulante de colonias de granulocito-macrofago (gm-csf) para tratar infecciones refractarias por micobacterias no tuberculosas. | |
EP3565551A4 (en) | METHOD FOR TREATMENT OF BACTERIAL INFECTION | |
WO2018211324A8 (en) | Prodrugs for the treatment of disease | |
MX2019010060A (es) | Composiciones y metodo para tratar cancer. | |
GEP20247590B (en) | Antibacterial quinolines | |
EP3691652A4 (en) | BACTERIAL INFECTION TREATMENT PROCESSES |